Certara (NASDAQ:CERT) Receives "Sell (D)" Rating from Weiss Ratings

Key Points

• Certara's stock has been reissued a "sell (D)" rating by Weiss Ratings, while other analysts have set diverse target prices ranging from $15.00 to $16.00.
• The company's latest quarterly earnings report showed a revenue increase of 12.1% year-over-year, but it missed the EPS estimate by $0.03.
• Insider selling was noted with Leif E. Pedersen disposing of 51,224 shares at an average price of $10.92, marking a significant reduction in their ownership position.

Certara (NASDAQ:CERT - Get Free Report)'s stock had its "sell (d)" rating reissued by equities research analysts at Weiss Ratings in a report issued on Wednesday,Weiss Ratings reports.

A number of other equities research analysts have also weighed in on the stock. Craig Hallum assumed coverage on shares of Certara in a report on Monday, September 29th. They set a "buy" rating and a $16.00 price objective on the stock. UBS Group dropped their price objective on shares of Certara from $17.50 to $15.00 and set a "buy" rating on the stock in a report on Thursday, August 7th. KeyCorp boosted their price objective on shares of Certara from $15.00 to $16.00 and gave the company an "overweight" rating in a report on Wednesday. Morgan Stanley began coverage on shares of Certara in a research report on Thursday, July 3rd. They set an "equal weight" rating and a $16.00 target price for the company. Finally, Zacks Research upgraded shares of Certara from a "strong sell" rating to a "hold" rating in a research report on Friday, September 5th. Six equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus target price of $15.63.

Certara Price Performance

Shares of Certara stock traded up $0.07 during trading on Wednesday, reaching $13.00. 1,499,880 shares of the stock traded hands, compared to its average volume of 2,080,406. The company has a market capitalization of $2.09 billion, a price-to-earnings ratio of 38.03 and a beta of 1.45. The business has a fifty day simple moving average of $11.17 and a two-hundred day simple moving average of $11.38. The company has a debt-to-equity ratio of 0.27, a current ratio of 2.16 and a quick ratio of 2.16. Certara has a 52-week low of $8.64 and a 52-week high of $15.69.

Certara (NASDAQ:CERT - Get Free Report) last released its quarterly earnings results on Wednesday, August 6th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.10 by ($0.03). The company had revenue of $104.57 million during the quarter, compared to analysts' expectations of $104.14 million. Certara had a return on equity of 5.11% and a net margin of 1.97%.The company's revenue was up 12.1% on a year-over-year basis. During the same quarter in the prior year, the business posted $0.07 EPS. Sell-side analysts expect that Certara will post 0.28 EPS for the current year.

Insider Buying and Selling at Certara

In related news, insider Leif E. Pedersen sold 51,224 shares of the stock in a transaction that occurred on Tuesday, September 9th. The shares were sold at an average price of $10.92, for a total transaction of $559,366.08. Following the completion of the transaction, the insider owned 73,979 shares of the company's stock, valued at approximately $807,850.68. This trade represents a 40.91% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 2.33% of the company's stock.

Institutional Investors Weigh In On Certara

A number of hedge funds and other institutional investors have recently modified their holdings of CERT. AdvisorNet Financial Inc acquired a new stake in Certara during the 2nd quarter worth $25,000. Caitong International Asset Management Co. Ltd acquired a new stake in Certara during the 1st quarter worth $31,000. AlphaQuest LLC acquired a new stake in Certara during the 1st quarter worth $39,000. Osaic Holdings Inc. raised its stake in Certara by 50.7% during the 2nd quarter. Osaic Holdings Inc. now owns 3,491 shares of the company's stock worth $41,000 after acquiring an additional 1,175 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC acquired a new stake in Certara during the 2nd quarter worth $59,000. 73.96% of the stock is currently owned by institutional investors and hedge funds.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.